APA (7th ed.) Citation

Seredavkina, N. V., Cheldieva, F. A., Shumilova, A. A., & Reshetnyak, T. M. (2023). Efficacy and safety of long-term use of low molecular weight heparins in patients with systemic lupus erythematosus and antiphospholipid syndrome. IMA-PRESS LLC.

Chicago Style (17th ed.) Citation

Seredavkina, N. V., F. A. Cheldieva, A. A. Shumilova, and T. M. Reshetnyak. Efficacy and Safety of Long-term Use of Low Molecular Weight Heparins in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome. IMA-PRESS LLC, 2023.

MLA (9th ed.) Citation

Seredavkina, N. V., et al. Efficacy and Safety of Long-term Use of Low Molecular Weight Heparins in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome. IMA-PRESS LLC, 2023.